About My Health Careers Internship MedBlogs Contact us

Targets for Therapies to Prevent or Delay Heart Failure Identified

by Chrisy Ngilneii on March 21, 2018 at 11:52 AM
Font : A-A+

Targets for Therapies to Prevent or Delay Heart Failure Identified

Heart failure from pressure overload of the heart may be prevented or delayed through suppression of the cells CCR2+ macrophages (immune cells) as they cause heart failure, research at the University of Alabama at Birmingham finds.

In a study published in the journal JACC: Basic to Translational Science, Sumanth Prabhu, M.D., and colleagues found that preventing the early infiltration of CCR2+ macrophages into the heart, after experimental pressure overload in a mouse model, significantly lessened the heart's enlargement and reduced pumping ability that leads to later heart failure. Thus, this infiltration is a required step in the path toward heart failure.


Macrophages are immune cells that engulf and remove damaged or dead cells in response to tissue injury or infection. They also may present antigens to other immune cell types.

The most common forms of pressure overload are aortic stenosis, a narrowing of the aortic valve of the heart that forces the heart muscle to overwork, and high blood pressure. Aortic stenosis affects about one in 50 people over 65 years of age.

The UAB researchers used two different methods to prevent early macrophage infiltration -- an inhibitor of the macrophage cell-surface CCR2 chemokine receptor, and an antibody that selectively removes CCR2+ macrophages. Migrating macrophages use the CCR2 receptor to home in on damaged tissues in the body that are releasing chemokines. Preventing early macrophage infiltration, Prabhu and colleagues say, may offer a therapeutic target in human disease.

Researchers had previously known that pressure-overload heart failure is associated with inflammation cause by activated T-cells. The present UAB study showed the link between infiltrating macrophages and the T-cell response during pressure overload of the heart.

Prabhu and colleagues found, one week after inducing pressure load that the heart showed increased expression of three attractant chemokines that are able to bind to the CCR2 receptor on macrophages. They also found an increased number of monocytes with the cell-surface markers Ly6C and CCR2 circulating in the blood, and they saw an eightfold increase in CCR2+ macrophages infiltrating into the heart. Those macrophages are derived from the circulating monocytes.

The UAB researchers suggest that increased circulating monocytes might serve as an easily measurable biomarker that reflects cardiac tissue CCR2+ macrophage expansion. The circulating monocytes, along with other clinical, imaging and biochemical biomarkers, could guide patient selection for a prospective clinical trial to find out whether modulating CCR2 macrophages in humans with pressure-overload hypertrophy will delay or prevent later transition to heart failure.

In the study, the Prabhu group found that blocking the infiltration of macrophages to the heart also suppressed infiltration of inflammatory T-cells into the heart and T-cell expansion in the lymph nodes that drain from the heart.

"Taken together, these data indicate that blood monocyte-derived macrophages infiltrating the heart early after pressure overload are indispensable for the sustained T-cell activation that underlies remodeling progression and the transition to heart failure," the researchers concluded.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amoebic Dysentery Congenital Heart Disease Heart Healthy Heart Pulmonary Arterial Hypertension Statins Mitral Valve Prolapse Aortic Valve Stenosis Infective Endocarditis Cough Symptom Evaluation 

Recommended Reading
Congestive Heart Failure
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump ...
Cardiogenic Shock
Cardiogenic shock is defined as reduced cardiac output due to inability of the heart to pump ......
Pulmonary Edema
Pulmonary edema or fluid in the lungs is caused by congestive heart failure and several other ......
Heart Cancer
Malignant heart cancer is extremely rare. Benign tumors of the heart too are rare, with early ......
Amoebic Dysentery
Amoebic dysentery or amoebiasis is an infection of the intestine that causes diarrhoea most frequent...
Aortic Valve Stenosis
Aortic valve Stenosis is an abnormal narrowing of the c valve. Symptoms include angina, and that of ...
Congenital Heart Disease
Heart diseases that are present at birth are called “ Congenital heart diseases”....
Cough Symptom Evaluation
Cough is a symptom of a condition usually affecting the respiratory tract. It may be acute or chroni...
Infective Endocarditis
Infective endocarditis has been arbitrarily categorized as acute or subacute based on the length of ...
Mitral Valve Prolapse
Mitral Valve Prolapse is a relatively common condition and causes leakage of blood through the valve...
Pulmonary Arterial Hypertension
It can be a serious condition affecting the heart. It is defined as mean pulmonary arterial pressure...
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use